Osang Healthcare Co.,Ltd (KOSDAQ:036220)
6,600.00
-160.00 (-2.37%)
Sep 21, 2026, 3:30 PM KST
Osang Healthcare Co.,Ltd Revenue
Osang Healthcare Co.,Ltd had revenue of 19.14B KRW in the quarter ending June 30, 2026, a decrease of -54.47%. This brings the company's revenue in the last twelve months to 96.48B, down -15.35% year-over-year. In the year 2025, Osang Healthcare Co.,Ltd had annual revenue of 128.63B with 59.81% growth.
Revenue (ttm)
96.48B
Revenue Growth
-15.35%
P/S Ratio
0.93
Revenue / Employee
290.60M
Employees
332
Market Cap
89.44B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 128.63B | 48.14B | 59.81% |
| Dec 31, 2024 | 80.49B | -275.36B | -77.38% |
| Dec 31, 2023 | 355.85B | 161.95B | 83.53% |
| Dec 31, 2022 | 193.89B | 61.57B | 46.53% |
| Dec 31, 2021 | 132.33B | -125.64B | -48.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DRTECH | 126.23B |
| Dongbang Medical | 125.12B |
| Ray Co., Ltd. | 119.17B |
| Shinhung | 105.89B |
| T&R Biofab | 32.73B |
| Humasis | 31.73B |
| Access Bio | 23.54B |
| Sugentech | 9.78B |